One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
What Is The Test For Alcohol Metabolite?March 11, 2024In the realm of diagnostic testing, understanding the body’s processing of substances such as alcohol is crucial for a myriad of applications, from clinical diagnostics to forensic analysis. CapitalB...view
Breaking Barriers: Innovations in Gynecologic Cancer TreatmentJune 26, 2023Gynecologic cancers, which include ovarian, uterine, cervical, vaginal, and vulvar cancers, affect thousands of women worldwide. The diagnosis of gynecologic cancer can be devastating, but thanks to o...view
Development Status and Future of In Vitro Diagnostic TechnologyDecember 15, 2022In vitro diagnostic technology refers to products and services that obtain relevant clinical diagnostic information by testing samples of the body including blood, body fluids, and tissues outside the...view
What Is The Most Accurate Alcohol Metabolism Test?March 11, 2024In the intricate domain of diagnostic testing, the quest for accuracy and reliability is perpetual. Among the myriad of tests, those aimed at deciphering alcohol metabolism stand out for their critica...view